A proportion of men with grade group 1 (GG1) prostate cancer have a higher-risk disease than suggested by biopsy, according ...

Immunotherapy uses the body's immune system to recognize and destroy cancer cells. One way to do this is through immune ...

Designating GG1 on biopsy as noncancer without considering the prognostic values of adverse clinical features may lead to undertreatment and an increased risk of cancer-specific death in men with ...

Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared to their White counterparts, data suggest.

National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF ...

Customs Kicking Cancer raises prostate cancer awareness in the motorcyclist and automobile enthusiast communities.

Researchers identified that triterpene glycosides from the starfish Solaster pacificus can kill drug-resistant prostate ...

ORIC's pipeline shows early promise, especially ORIC-944 in prostate cancer and well-funded through 2027, but safety risks ...

Cleveland Diagnostics — spun off from Cleveland Clinic Innovations — has a unique prostate test that has seen the business ...

Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is highly expressed in prostate cancer cells. PSMA-based imaging and therapy have ...

A Grimsby taxi driver successfully treated for prostate cancer decided to take two wheels instead of four to give back to a ...

Designed to expand PSMA PET imaging access for patients by increasing batch size by ~50% and enhancing supply resiliencePDUFA date set for March 6, 2026 BEDFORD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) ...